Achieved $49.3 million in OGSIVEO ® (nirogacestat) net product revenue in the third quarter – – Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors ...
When the mercury’s a-droppin’, sales come a-knockin’. Every keen shopper knows that the best bargain events occur as the weather undergoes a downward shift. Expert retail enthusiasts, however, will ...